当前位置: X-MOL 学术J. Enzyme Inhib. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Synthesis, computational studies and assessment of in vitro inhibitory activity of umbelliferon-based compounds against tumour-associated carbonic anhydrase isoforms IX and XII.
Journal of Enzyme inhibition and Medicinal Chemistry ( IF 5.6 ) Pub Date : 2020-07-02 , DOI: 10.1080/14756366.2020.1786821
Francesca Mancuso 1 , Laura De Luca 1 , Andrea Angeli 2 , Sonia Del Prete 3 , Clemente Capasso 3 , Claudiu T Supuran 2 , Rosaria Gitto 1
Affiliation  

Abstract

Coumarins are widely diffused secondary metabolites possessing a plethora of biological activities. It has been established that coumarins represent a peculiar class of human carbonic anhydrase (hCA) inhibitors having a distinct mechanism of action involving a non-classical binding with amino acid residues paving the entrance of hCA catalytic site. Herein, we report the synthesis of a small series of new coumarin derivatives 7-11, 15, 17 prepared via classical Pechmann condensation starting from resorcinol derivatives and suitable β-ketoesters. The evaluation of inhibitory activity revealed that these compounds possessed nanomolar affinity and high selectivity towards tumour-associated hCA IX and XII over cytosolic hCA I and hCA II isoforms. To investigate the binding mode of these new coumarin-inspired inhibitors, the most active compounds 10 and 17 were docked within hCA XII catalytic cleft.



中文翻译:

伞形虫基化合物对与肿瘤相关的碳酸酐酶同工型IX和XII的体外抑制活性的合成,计算研究和评估。

摘要

香豆素是广泛散布的次级代谢产物,具有多种生物学活性。已经确定,香豆素代表一类特殊的人类碳酸酐酶(hCA)抑制剂,具有独特的作用机制,涉及与非经典结合的氨基酸残基铺平了hCA催化位点的入口。在这里,我们报告的小编新的香豆素衍生物的合成7-111517由间苯二酚衍生物和合适的β-酮酸酯通过经典的Pechmann缩合制备。抑制活性的评估表明,这些化合物相对于胞质hCA I和hCA II同种型具有纳摩尔摩尔亲和力和对肿瘤相关hCA IX和XII的高选择性。为了研究这些新的香豆素类抑制剂的结合方式,将活性最高的化合物1017停靠在hCA XII催化裂隙内。

更新日期:2020-07-02
down
wechat
bug